Discovery of TCP-(MP)-caffeic acid analogs as a new class of agents for treatment of osteoclastic bone loss.
Chen Z, Choi ER, Encarnacion AM, Yao H, Ding M, Park YH, Choi SM, An YJ, Hong E, Choi HJ, Kim SK, Nam YE, Kim GJ, Park SW, Kim JS, Kim E, Lee S, Cho JH, Lee TH.
Chen Z, et al. Among authors: encarnacion am.
Bioorg Chem. 2024 Sep;150:107603. doi: 10.1016/j.bioorg.2024.107603. Epub 2024 Jul 1.
Bioorg Chem. 2024.
PMID: 38968905